About Genotypic
Genotypic is a company based in Bengaluru (India) founded in 1998. Genotypic has raised $171.23 thousand across 1 funding round from investors including Sadanand Bopat and Anuja Vivek Joshi. The company has 82 employees as of April 06, 2024. Genotypic offers products and services including Commander Software, Nanopore Sequencing, Microarray Services, and Bioinformatics Services. Genotypic operates in a competitive market with competitors including Helix, Strand Life Sciences, Benchling, Genuity Science and Inpharmatica, among others.
- Headquarter Bengaluru, India
- Employees 82 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genotypic Technology Private Limited
- Date of Incorporation 09 Oct, 1998
- Jurisdiction Bangaluru, Karnataka, India
-
Annual Revenue
$5.53 M (USD)60.48as on Mar 31, 2023
-
Net Profit
$488.15 K (USD)62.34as on Mar 31, 2023
-
EBITDA
$953 K (USD)38.03as on Mar 31, 2023
-
Total Equity Funding
$171.23 K (USD)
in 1 rounds
-
Latest Funding Round
$171.23 K (USD), Angel Round
Mar 31, 2006
-
Investors
& 1 more
-
Employee Count
82
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genotypic
Genotypic offers a comprehensive portfolio of products and services, including Commander Software, Nanopore Sequencing, Microarray Services, and Bioinformatics Services.
Tool for simplifying NGS data analysis and processing.
Provides DNA sequencing using Nanopore technology.
Offers gene expression analysis and profiling services.
Delivers integrated data analysis for genomic projects.
Funding Insights of Genotypic
Genotypic has successfully raised a total of $171.23K through 1 strategic funding round. The most recent funding activity was a Angel Round of $171.23 thousand completed in March 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genotypic
Genotypic has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Sadanand Bopat and Anuja Vivek Joshi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SB
Sadanand Bopat |
-
|
Locked | Locked | Locked |
|
AV
Anuja Vivek Joshi |
-
|
Locked | Locked | Locked |
Investor details for Genotypic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genotypic
Investment portfolio details for Genotypic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genotypic
Detailed financials for Genotypic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genotypic Comparisons
Peer comparison for Genotypic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genotypic
Genotypic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Strand Life Sciences, Benchling, Genuity Science and Inpharmatica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
Detailed competitors of Genotypic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genotypic
Complete news archive for Genotypic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genotypic
Genotypic was founded in 1998 and raised its 1st funding round 8 years after it was founded.
Genotypic is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Genotypic is a funded company, having raised a total of $171.23K across 1 funding round to date.
As of Apr 06, 2024, the latest employee count at Genotypic is 82.
Annual revenue of Genotypic is $5.53M as on Mar 31, 2023.
Provider of genomics and bioinformatics services. It provides genomic analysis using microarrays, next-generation sequencing (NGS), and bioinformatics services and solutions to domesticinternational pharma, biotech companies, and academia. The company has six products which include catalog microarrays, Biointerpreter which is a web-based biological interpretation tool for microarrays, Medrunner which extracts relevant information from PubMed abstracts, PubMine that extracts relevant information from MedLine abstracts, SeqQC for quality control and reporting of NGS data, and BioIT for IT solutions.
Genotypic's top competitors include Strand Life Sciences, Helix and Benchling.
Genotypic offers Commander Software, Nanopore Sequencing, Microarray Services, and Bioinformatics Services.
Genotypic has 2 investors. Key investors include Sadanand Bopat, and Anuja Vivek Joshi.
The valuation of Genotypic is $381.26K as of Mar 2006.